Epoetin Alfa Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Reference Brands: EPOGEN (USA), PROCRIT (USA)
Category:
Anemia
Epoetin alfa is a recombinant human erythropoietin that stimulates red blood cell production in the bone marrow. It is primarily used to treat anemia caused by chronic kidney disease, chemotherapy, or certain HIV treatments. Administered by injection, it helps reduce the need for blood transfusions in patients with low hemoglobin levels. Marketed under brand names such as Epogen, Procrit, and Eprex, this biologic drug has become a key therapy for managing anemia due to insufficient erythropoietin production.
Epoetin alfa is available in injection (prefilled syringe)
and strengths such as 1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Epoetin alfa is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Epoetin alfa can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing